Orthopediatrics (KIDS) Common Equity (2016 - 2026)
Orthopediatrics has reported Common Equity over the past 12 years, most recently at $338.7 million for Q1 2026.
- For Q1 2026, Common Equity fell 2.43% year-over-year to $338.7 million; the TTM value through Mar 2026 reached $338.7 million, down 2.43%, while the annual FY2025 figure was $346.6 million, 2.25% down from the prior year.
- Common Equity for Q1 2026 was $338.7 million at Orthopediatrics, down from $346.6 million in the prior quarter.
- Over five years, Common Equity peaked at $383.3 million in Q3 2022 and troughed at $215.0 million in Q1 2022.
- A 5-year average of $347.9 million and a median of $370.6 million in 2024 define the central range for Common Equity.
- Biggest five-year swings in Common Equity: skyrocketed 73.52% in 2023 and later fell 6.32% in 2025.
- Year by year, Common Equity stood at $378.6 million in 2022, then fell by 0.43% to $377.0 million in 2023, then fell by 5.96% to $354.6 million in 2024, then dropped by 2.25% to $346.6 million in 2025, then dropped by 2.27% to $338.7 million in 2026.
- Business Quant data shows Common Equity for KIDS at $338.7 million in Q1 2026, $346.6 million in Q4 2025, and $349.3 million in Q3 2025.